These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 17691161

  • 1. Metabolic syndrome in drug-naïve first-episode psychosis treated with atypical antipsychotics.
    Sahoo S, Ameen S, Akhtar S.
    Aust N Z J Psychiatry; 2007 Jul; 41(7):629. PubMed ID: 17691161
    [No Abstract] [Full Text] [Related]

  • 2. Metabolic changes in first-episode early-onset schizophrenia with second-generation antipsychotics.
    O'Donoghue B, Schäfer MR, Becker J, Papageorgiou K, Amminger GP.
    Early Interv Psychiatry; 2014 Aug; 8(3):276-80. PubMed ID: 23968390
    [Abstract] [Full Text] [Related]

  • 3. Incidence of new onset metabolic syndrome with atypical antipsychotics in first episode schizophrenia: a six-week prospective study in Indian female patients.
    Saddichha S, Ameen S, Akhtar S.
    Schizophr Res; 2007 Sep; 95(1-3):247. PubMed ID: 17644311
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The appearance of metabolic syndrome in treatment with atypical antipsychotics].
    Mosolov SN, Kabanov SO.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003 Sep; 103(11):62-9. PubMed ID: 14681970
    [No Abstract] [Full Text] [Related]

  • 6. [Lipid spectrum changes and ECG in patients with paranoid schizophrenia in the course of therapy with atypical antipsychotics].
    Smirnova LP, Parshukova DA, Borodyuk YN, Kornetova EG, Tkacheva GD, Seregin AA, Burdovitsina TG, Semke AV.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015 Sep; 115(3):49-53. PubMed ID: 26120982
    [Abstract] [Full Text] [Related]

  • 7. Two new atypical antipsychotics: advantages and disadvantages.
    Lemon MD.
    S D J Med; 1998 Aug; 51(8):285-6. PubMed ID: 9724957
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Sexual disturbances during the treatment with neuroleptics in patients with schizophrenia and schizophrenia spectrum disorders].
    Iagubov MI, Shtark LN.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011 Aug; 111(9 Pt 2):57-60. PubMed ID: 22027609
    [Abstract] [Full Text] [Related]

  • 10. [Efficacy of atypical antipsychotics in patients with Alzheimer's dementia. CATIE-AD-Study (Clinical Antipsychotic Trials of Intervention Effectiveness Alzheimer's Disease)].
    Förstl H.
    Internist (Berl); 2007 Jun; 48(6):642-4. PubMed ID: 17497111
    [No Abstract] [Full Text] [Related]

  • 11. Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia.
    Mullins CD, Obeidat NA, Cuffel BJ, Naradzay J, Loebel AD.
    Schizophr Res; 2008 Jan; 98(1-3):8-15. PubMed ID: 17596914
    [Abstract] [Full Text] [Related]

  • 12. Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia.
    Ollendorf DA, Joyce AT, Rucker M.
    MedGenMed; 2004 Jan 20; 6(1):5. PubMed ID: 15208518
    [Abstract] [Full Text] [Related]

  • 13. The value of atypical antipsychotics in the treatment of schizophrenia.
    Jessen LM.
    Manag Care; 2002 Jul 20; 11(7 Suppl):8-12; discussion 12-3. PubMed ID: 12181875
    [No Abstract] [Full Text] [Related]

  • 14. Tardive dyskinesia rates with atypical antipsychotics in older adults.
    Jeste DV.
    J Clin Psychiatry; 2004 Jul 20; 65 Suppl 9():21-4. PubMed ID: 15189108
    [Abstract] [Full Text] [Related]

  • 15. [Effect of side-effects and complications caused by atypical neuroleptics on the effectiveness of therapy in patients with schizophrenia].
    Danilov DS.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010 Jul 20; 110(3):48-55. PubMed ID: 20517226
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.
    Stroup TS, Lieberman JA, McEvoy JP, Swartz MS, Davis SM, Capuano GA, Rosenheck RA, Keefe RS, Miller AL, Belz I, Hsiao JK, CATIE Investigators.
    Am J Psychiatry; 2007 Mar 20; 164(3):415-27. PubMed ID: 17329466
    [Abstract] [Full Text] [Related]

  • 17. Thyroid dysfunction during treatment with atypical antipsychotics.
    Greenspan A, Gharabawi G, Kwentus J.
    J Clin Psychiatry; 2005 Oct 20; 66(10):1334-5. PubMed ID: 16259552
    [No Abstract] [Full Text] [Related]

  • 18. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
    Dossenbach M, Erol A, el Mahfoud Kessaci M, Shaheen MO, Sunbol MM, Boland J, Hodge A, O'Halloran RA, Bitter I, IC-SOHO Study Group.
    J Clin Psychiatry; 2004 Mar 20; 65(3):312-21. PubMed ID: 15096069
    [Abstract] [Full Text] [Related]

  • 19. A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization.
    Potkin SG, Gharabawi GM, Greenspan AJ, Mahmoud R, Kosik-Gonzalez C, Rupnow MF, Bossie CA, Davidson M, Burtea V, Zhu Y, Trivedi JK.
    Schizophr Res; 2006 Jul 20; 85(1-3):254-65. PubMed ID: 16797162
    [Abstract] [Full Text] [Related]

  • 20. Randomized Trial of the Effect of Four Second-Generation Antipsychotics and One First-Generation Antipsychotic on Cigarette Smoking, Alcohol, and Drug Use in Chronic Schizophrenia.
    Mohamed S, Rosenheck RA, Lin H, Swartz M, McEvoy J, Stroup S.
    J Nerv Ment Dis; 2015 Jul 20; 203(7):486-92. PubMed ID: 26075840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.